Free tool
FAERS Monitor: Acetadote
Last checked: Nov 21, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021539 or its brand name (Acetadote, Acetylcysteine). Reports on generic versions are filed under their own applications.
Reports
9,625
Serious
8,567
89% of reports
Hospitalization
5,194
Death reported
1,796
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dyspnoea800
- off label use680
- drug ineffective679
- pneumonia651
- pyrexia520
- fatigue468
- nausea453
- diarrhoea379
- vomiting342
- death333
- cough323
- hypertension318
- chronic obstructive pulmonary disease311
- hypotension303
- condition aggravated301
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 176 |
| 2005 | 136 |
| 2006 | 154 |
| 2007 | 126 |
| 2008 | 194 |
| 2009 | 190 |
| 2010 | 270 |
| 2011 | 284 |
| 2012 | 281 |
| 2013 | 166 |
| 2014 | 204 |
| 2015 | 285 |
| 2016 | 288 |
| 2017 | 273 |
| 2018 | 430 |
| 2019 | 517 |
| 2020 | 597 |
| 2021 | 774 |
| 2022 | 799 |
| 2023 | 929 |
| 2024 | 872 |
| 2025 | 951 |
| 2026 | 728 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,044,534 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| chronic obstructive pulmonary diseaseSignal | 311 | 13.1 | 11.7 | 3,451 |
| pneumoniaSignal | 651 | 4.4 | 4.1 | 1,731 |
| pyrexiaSignal | 520 | 3.3 | 3.0 | 838 |
| hypertensionSignal | 318 | 3.3 | 2.9 | 507 |
| dyspnoeaSignal | 800 | 3.1 | 2.9 | 1,159 |
| coughSignal | 323 | 2.5 | 2.3 | 298 |
| condition aggravatedSignal | 301 | 2.2 | 1.9 | 190 |
| off label use | 680 | 1.7 | 1.6 | 202 |
| vomiting | 342 | 1.6 | 1.4 | 76 |
| fatigue | 468 | 1.3 | 1.2 | 36 |
| diarrhoea | 379 | 1.3 | 1.2 | 24 |
| nausea | 453 | 1.3 | 1.1 | 23 |
| drug ineffective | 679 | 1.1 | 1.0 | 10 |
| death | 333 | 0.8 | 0.8 | 10 |
| hypotension | 303 | 0.0 | 0.0 | 660,317 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.